<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">This trial is designed to determine whether azithromycin is effective in preventing progression to severe respiratory failure requiring ventilatory support or death in adult patients with clinically diagnosed COVID-19 infection being assessed in secondary care but initially managed on an ambulatory care pathway. This specific situation provides a therapeutic window of opportunity to avert development of more severe disease.</p>
